Rani Therapeutics Stock Quote RANI - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

6.37

Bid

4.60

Ask

7.33

Volume

0.00 Day's Range 0.00

1.82 52 Week Range 8.75

Market Cap

318.478M

Previous Close

6.37

Open

Last Trade

6.17

Last Trade Time

04:24:42

Financial Volume

VWAP

Average Volume (3m)

131,859

Shares Outstanding

49,996,508

Dividend Yield

PE Ratio

-9.38

Earnings Per Share (EPS)

-0.68

Revenue

Net Profit

-33.97M

Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injecti... Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.ranitherapeutics.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Rani Therapeutics Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RANI. The last closing price for Rani Therapeutics was $6.37. Over the last year, Rani Therapeutics shares have traded in a share price range of $ 1.82 to $ 8.75.

Rani Therapeutics currently has 49,996,508 shares outstanding. The market capitalization of Rani Therapeutics is $318.48 million. Rani Therapeutics has a price to earnings ratio (PE ratio) of -9.38.

Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111)

- RT-111 achieved high bioavailability in humans - - RT-111 was well-tolerated, with no serious adverse events - - Celltrion has right of first negotiation to acquire worldwide rights to RT-111...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.65	-9.25925925926	7.02	7.2274	5.8	103483	6.50462502	CS
4	3.02	90.1492537313	3.35	8.75	3.3	243894	6.42386156	CS
12	2.59	68.5185185185	3.78	8.75	2.85	131859	5.33264298	CS
26	4.405	224.17302799	1.965	8.75	1.82	116264	4.25828085	CS
52	1.37	27.4	5	8.75	1.82	85197	4.04763002	CS
156	-4.89	-43.4280639432	11.26	36.27	1.82	84343	11.36223913	CS
260	-4.89	-43.4280639432	11.26	36.27	1.82	84343	11.36223913	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NUVOHoldco Nuvo Group DG Ltd	7.99 (3,531.82%)	90
APVOAptevo Therapeutics Inc	$ 1.38 (43.75%)	1.2M
TRSGTungray Technologies Inc	$ 7.74 (25.85%)	101
ENVXEnovix Corporation	$ 7.96 (22.27%)	47.15k
LUNGPulmonx Corporation	$ 9.04 (17.10%)	128
FRSHFreshworks Inc	$ 13.14 (-28.00%)	14.07k
RELYRemitly Global Inc	$ 14.58 (-16.88%)	139
FBYDFalcons Beyond Global Inc	$ 8.00 (-14.35%)	16
DASHDoorDash Inc	$ 110.13 (-13.60%)	3.84k
CTMXCytomX Therapeutics Inc	$ 4.47 (-12.87%)	213.25k
FFIEFaraday Future Intelligent Electric Inc	$ 0.0517 (12.15%)	2.32M
APVOAptevo Therapeutics Inc	$ 1.38 (43.75%)	1.2M
SQQQProShares UltraPro Short QQQ	$ 11.91 (-2.54%)	568.8k
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 8.41 (4.99%)	443.93k
TSLATesla Inc	$ 184.50 (2.51%)	240.35k